We observed that BloodCCD score improved with patient-reported ISI scores in the YOCAS and the behavioral placebo (SHE), while in the CBT-I arm this trend was present but did not reach statistical significance.
← all excerpts
Blood Clock Correlation Distance (BloodCCD) as a novel marker to detect circadian rhythm disruption in cancer survivors with insomnia.
1
—
—